Bayer AG (BAYRY)
14.46
+0.14
(+0.98%)
USD |
OTCM |
Sep 28, 16:00
Bayer Market Cap : 56.82B for Sept. 28, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 28, 2026 | 56.82B |
| September 25, 2026 | 56.27B |
| September 24, 2026 | 55.49B |
| September 23, 2026 | 55.33B |
| September 22, 2026 | 55.72B |
| September 21, 2026 | 55.17B |
| September 18, 2026 | 54.07B |
| September 17, 2026 | 55.53B |
| September 16, 2026 | 55.21B |
| September 15, 2026 | 55.15B |
| September 14, 2026 | 56.08B |
| September 11, 2026 | 54.82B |
| September 10, 2026 | 55.29B |
| September 09, 2026 | 56.23B |
| September 08, 2026 | 56.27B |
| September 04, 2026 | 55.76B |
| September 03, 2026 | 56.37B |
| September 02, 2026 | 55.88B |
| September 01, 2026 | 55.49B |
| August 31, 2026 | 56.00B |
| August 28, 2026 | 55.09B |
| August 27, 2026 | 55.45B |
| August 26, 2026 | 56.00B |
| August 25, 2026 | 56.35B |
| August 24, 2026 | 55.49B |
| Date | Value |
|---|---|
| August 21, 2026 | 55.25B |
| August 20, 2026 | 55.49B |
| August 19, 2026 | 56.47B |
| August 18, 2026 | 55.47B |
| August 17, 2026 | 54.39B |
| August 14, 2026 | 54.39B |
| August 13, 2026 | 54.39B |
| August 12, 2026 | 54.66B |
| August 11, 2026 | 56.08B |
| August 10, 2026 | 55.80B |
| August 07, 2026 | 56.74B |
| August 06, 2026 | 56.27B |
| August 05, 2026 | 55.96B |
| August 04, 2026 | 54.94B |
| August 03, 2026 | 53.33B |
| July 31, 2026 | 54.58B |
| July 30, 2026 | 54.90B |
| July 29, 2026 | 53.60B |
| July 28, 2026 | 53.01B |
| July 27, 2026 | 52.62B |
| July 24, 2026 | 51.60B |
| July 23, 2026 | 51.60B |
| July 22, 2026 | 52.42B |
| July 21, 2026 | 53.44B |
| July 20, 2026 | 52.78B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Merck KGaA | 20.46B |
| Breakthrough Chemistry, Inc. | 0.9243M |
| Cardiac Biotech Solutions, Inc. | 5.360M |
| Fresenius SE & Co. KGaA | 30.08B |
| Carl Zeiss Meditec AG | 3.146B |
Market Cap Related Metrics
| PS Ratio | 1.074 |
| Price to Book Value | 1.68 |
| Price to Free Cash Flow | 76.92 |
| Price | 14.46 |
| Earnings Yield | -3.54% |
| Operating PE Ratio | 7.772 |
| Normalized PE Ratio | 29.28 |